Functional Imaging of Proteolysis: Stromal and Inflammatory Cells Increase Tumor Proteolysis

Molecular Imaging

Volumn 2, Issue 3, 2003, Pages 159-175

  Sameni, Mansoureh ^a   Dosescu, Julie ^a   Moin, Kamiar ^a   Sloane, Bonnie F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cysteine proteases; Laser scanning confocal microscopy; Matrix metalloproteinases; Quenched fluorescent collagen IV; Serine proteases

Indexed keywords

CELLS; FLUORESCENCE; MEDICAL IMAGING; TUMORS;

SERINE PROTEASES; TUMOR PROTEOLYSIS;

PROTEINS;

BB 3103; COLLAGEN; COLLAGEN TYPE 4; HYDROXAMIC ACID; LAMININ; MATRIGEL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEINASE; PROTEOGLYCAN;

ARTICLE; BREAST TUMOR; CARCINOMA; CELL DIFFERENTIATION; CELL MOTION; CELL STRAIN U937; CELL SURVIVAL; COCULTURE; COLON TUMOR; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; ENZYMOLOGY; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MACROPHAGE; METABOLISM; MONOCYTE; MULTICELLULAR SPHEROID; NEOPLASM; PATHOLOGY; STROMA CELL; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; COCULTURE TECHNIQUES; COLLAGEN; COLLAGEN TYPE IV; COLONIC NEOPLASMS; DRUG COMBINATIONS; ENDOPEPTIDASES; HUMANS; HYDROXAMIC ACIDS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LAMININ; MACROPHAGES; MONOCYTES; NEOPLASMS; PROTEOGLYCANS; SPHEROIDS, CELLULAR; STROMAL CELLS; TETRADECANOYLPHORBOL ACETATE; U937 CELLS;

EID: 0242577116     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535003322556903     Document Type: Article

References (52)

1. Maguire TM, Shering SG, Duggan CM, McDermott EW, O'Higgins NJ, Duffy MJ (1998). High levels of cathepsin B predict poor outcome in patients with breast cancer. Int J Biol Markers. 13:139-144.
2. Baker EA, Bergin FG, Leaper DJ (2000). Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg. 87:1215-1221.
3. Hazen LG, Bleeker FE, Lauritzen B, Bahns S, Song J, Jonker A, Van Driel BE, Lyon H, Hansen U, Kohler A, van Noorden, CJ (2000). Comparative localization of cathepsin B protein and activity in colorectal cancer. J Histochem Cytochem. 48:1421-1430.
4. Heylen N, Vincent LM, Devos V, Dubois V, Remade C, Trouet A (2002). Fibroblasts capture cathepsin D secreted by breast cancer cells: Possible role in the regulation of the invasive process. Int J Oncol. 20:761-767.
5. McKerrow JH, Bhargava V, Hansell E, Huling S, Kuwahara T, Matley M, Coussens L, Warren R (2000). A functional proteomics screen of proteases in colorectal carcinoma. Mol Med. 6:450-460.
6. Tetu B, Brisson J, Wang CS, Lapointe H, Beaudry G, Blanchette C (2001), Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis. Cancer. 92:2957-2964.
7. Baker EA, Stephenson TJ, Reed MW, Brown NJ (2002). Expression of proteinases and inhibitors in human breast cancer progression and survival, Mol Pathol. 55:300-304.
8. Bremer C, Tung CH, Bogdanov Jr A, Weissleder R (2002). Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology. 222:814-818.
9. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL (2003). Regulation of colon carcinoma cell invasion by hypoxiainducible factor 1. Cancer Res. 63:1138-1143.
10. Hauptmann S, Zardi L, Siri A, Carnemolla B, Borsi L. Castellucci M, Klosterhalfen B, Hartung P, Weis J, Stocker G, Haubeck, DH, Kirkpatrick CJ (1995). Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Invest. 73:172-182
11. Khan A, Krishna M, Baker SP, Banner BF (1998). Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma. Mod Pathol. 11:704-708.
12. Zeng ZS, Cohen AM, Guillem JG (1999). Loss of basement membrane type IV collagen is associated with increased expression of metalloproteases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis. 20:749-755.
13. Zheng WQ, Looi LM, Cheah PL (2001). A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma. Pathology. 33:303-306.
14. Amenta PS, Hadad S, Lee MT, Barnard N, Li D, Myers JC (2003). Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast. J Pathol. 199:298-308.
15. Sameni M, Moin K, Sloane BF (2000). Imaging proteolysis by living human breast cancer cells. Neoplasia. 2:496-504.
16. Sameni M, Dosescu J, Sloane BF (2001). Imaging proteolysis by living human glioma cells, Biol Chem. 382:785-788.
17. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, Emmert-Buck MR (1994). Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol. 145:301-309.
18. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response, Am J Pathol. 149:273-282.
19. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Dano K (1996). 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer. 65:57-62,
20. Ornstein DL, MacNab J, Cohn KH (1999). Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer. Clin Exp Metastasis. 17:205-212.
21. Moin K, Day NA, Sameni M, Hasnain S, Hirama T and Sloane BF (1992). Human tumour cathepsin B: Comparison with normal human liver cathepsin B. Biocbem J. 285:427-434.
22. Murata M, Miiyashta S, Yokoo C, Tamai M, Hanada K, Hatayama K, Towatari T, Nikawa T, Katunuma N (1991). Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett. 280:307-310.
23. Buttle DJ, Murata M, Knight CG and Barrett AJ (1992). CA074 methy ester: A proinhibitor for intracellular cathepsin B. Arch Biocbem Biophys. 299:377-380.
24. Demchik L, Sameni M, Nelson K, Rozhin J, Mikkelsen T, Sloane BF (1999). Cathepsin B and glioma invasion. Intl J Dev Neurosci. 17:483-494.
25. Van Noorden CJ, Jonges TG, Van Marle J, Bissell ER, Griffini P, Jans M, Snel J, Smith RE (1998). Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B. Clin Exp Metastasis. 16:159-167,
26. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T (1993). Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science. 260:85-88,
27. Okada F, Rak JW, Croix BS, Lieubeau B, Kaya M, Roncari L, Shirasawa S, Sasazuki T, Kerbel RS (1998). Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells, Proc Natl Acad Sci USA. 95:3609-3614.
28. Koretz K, Moller P, Schwartz-Albiez R (1993). Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells. Eur J Cancer. 29A:1184-1189.
29. Ohtani H, Pyke C, Dano K, Nagura H (1995). Expression of urokinase receptor in various stromal-cell populations in human colon cancer: Immunoelectron microscopical analysis. Int J Cancer. 62:691-696,
30. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Dano K (1991). Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas, Am J Pathol. 138:1059-1067.
31. Lah TT, Kalman E, Najjar D, Gorodetsky E, Brennan P, Somers R, Daskal I (2000). Cells producing cathepsins D, B, L in human breast carcinoma and their association with prognosis. Hum Pathol 31:149-160.
32. Koblinski JE, Dosescu J, Sameni M, Moin, K, Clark K, Sloane BF (2002). Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J Biol Chem. 277:32220-32227.
33. Egeblad M, Werb Z (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2:161-174.
34. Lynch CC, Matrisian LM (2002). Matrix metalloproteinases in tumor-host cell communication. Differentiation. 70:561-573.
35. Friedl P, Wolf K (2003). Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer. 3:362-374.
36. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56: 4625-4629.
37. Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M (2000). Angiogenin expression in human colorectal cancer: The role of focal macrophage infiltration. Clin Cancer Res. 6:3545-351.
38. Roeb E, Dietrich CG, Winograd R, Arndt M, Breuer B, Fass J, Schumpelick V, Matern S (2001). Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer. 92: 2680-2691,
39. Higashi N, Ishii H, Fujiwara T, Morimoto-Tomita M, Irimura T (2002). Redistribution of fibroblasts and macrophages as micro-metastases develop into established liver metastases. Cliin Exp Metastasis. 19:631-638.
40. Leek RD, Harris AL (2002). Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia. 7: 177-189.
41. Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL (2002). Relation of hypoxia-inducible factor 2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res. 62:1326-1329.
42. Seidl P, Huettinger R, Knuechel R, Kunz-Schughart LA (2002). Three-dimensional fibroblast-tumor cell interaction causes downregulation of RACK1 mRNA expression in breast cancer cells in vitro. Int J Cancer. 102:129-136.
43. Bisson C, Blacher S, Polette M, Blanc JF, Kebers F, Desreux J, Tetu B, Rosenbaum J, Foidart JM, Birembaut P, Noel A (2003). Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer. 105:7-13.
44. Himelstein BP, Muschel RJ (1996). Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts. Clin Exp Metastasis. 14:197-208.
45. Pourreyron C, Dumortier J, Ratineau C, Nejjari M, Beatrix O, Jacquier MF, Remy L, Chayvialle JA, Scoazec JY (2003). Agedependent variations of human and rat colon myofibroblasts in culture: Influence on their functional interactions with colon cancer cells. Int J Cancer. 104:28-35.
46. Engelholm LH, Nielsen BS, Dano K, Behrendt N (2001), The urokinase receptor associated protein (uPARAP/endo180): A novel internalization receptor connected to the plasminogen activation system. Trends Cardiovasc Med. 1:7-13.
47. Engelholm LH, List K, Netzel-Arnett S, Cukierman E, Mitola DJ, Aaronson H, Kjoller L, Larsen JK, Yamada KM, Strickland DK, Holmbeck K, Dano K, Birkedal-Hansen H, Bugge T (2003). uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion. J Cell Biol. 160: 1009-1015.
48. Greenbaum DC, Arnold WD, Lu F, Hayrapetian L, Baruch A, Krumrine J, Toba S, Chehade K, Bromme D, Kuntz ID, Bogyo, M (2002). Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem Biol. 9:1085-1094.
49. Bogyo M, Verhelst S, Bellingard-Dubouchaud V, Toba S, Greenbaum D (2000). Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs, Chem Biol. 7:27-38.
50. Bremer C, Bredow. S, Mahmood U, Weissleder R, Tung CH (2001). Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model. Radiology. 221:523-529.
51. Bremer C, Tung CH, Weissleder R (2001), In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med. 7:743-748.
52. Marten K, Bremer C, Khazaie K, Sameni M, Sloane B, Tung CH, Weissleder R (2002). Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice, Gastroenterology, 122:406-414.